Aurora Martinez

Title: Aurora Martinez: Innovator in Pharmacological Treatments

Introduction

Aurora Martinez is a notable inventor based in Eidsvågneset, Norway. She has made significant contributions to the field of pharmacology, particularly in the treatment of hyperphenylalaninemia. Her innovative work has led to the development of compounds that serve as pharmacological chaperones, which stabilize phenylalanine hydroxylase (PAH) for effective treatment.

Latest Patents

Aurora holds a patent for her invention titled "Hyperphenylalaninemia and treatments thereof." This patent relates to compounds of formula (I) that are designed for use as pharmacological chaperones. These compounds, including trimethoprim and its analogues and derivatives, are aimed at treating hyperphenylalaninemia, especially phenylketonuria (PKU). She has 1 patent registered under her name.

Career Highlights

Throughout her career, Aurora has worked with various organizations that focus on technological advancements and innovation. Notably, she has been associated with Bergen Teknologioverføring AS and Vestlandets Innovasjonsselskap AS. These experiences have allowed her to contribute to the development of groundbreaking solutions in her field.

Collaborations

Aurora has collaborated with talented individuals such as Oscar Aubi Catevilla and Ming Ying. These partnerships have enriched her work and expanded the impact of her inventions.

Conclusion

Aurora Martinez is a pioneering inventor whose work in pharmacological treatments has the potential to significantly improve the lives of individuals affected by hyperphenylalaninemia. Her dedication to innovation and collaboration continues to drive advancements in this critical area of healthcare.